Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease?
- PMID: 35748848
- DOI: 10.1111/apt.17041
Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease?
Comment in
-
Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease? Authors' reply.Aliment Pharmacol Ther. 2022 Jul;56(2):378-379. doi: 10.1111/apt.17060. Aliment Pharmacol Ther. 2022. PMID: 35748850 No abstract available.
Comment on
-
Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala.Aliment Pharmacol Ther. 2022 Jul;56(2):321-329. doi: 10.1111/apt.16948. Epub 2022 Apr 28. Aliment Pharmacol Ther. 2022. PMID: 35484638 Free PMC article.
References
REFERENCES
-
- Rivera-Andrade A, Petrick JL, Alvarez CS, Graubard BI, Florio AA, Kroker-Lobos MF, et al. Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala. Aliment Pharmacol Ther. 2022;56:321-329.
-
- Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313-24.
-
- Yki-Järvinen H. Diagnosis of non-alcoholic fatty liver disease (NAFLD). Diabetologia. 2016;59:1104-11.
-
- Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
-
- Jones GS, Alvarez CS, Graubard BI, McGlynn KA. Agreement between the prevalence of nonalcoholic fatty liver disease determined by transient elastography and fatty liver indices. Clin Gastroenterol Hepatol. 2022;20:227-229.e2.
Publication types
MeSH terms
LinkOut - more resources
Medical